Robert E. Landry - 10 Feb 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Non-Qualified Stock Option (Right to Buy)	Award	$0	+25,538		$0.000000	25,538	10 Feb 2025	Common Stock	25,538	$42.21	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Initial grant to new director. Stock Options vest monthly over 3-years from the date of grant.